Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma.
Touzeau C, Perrot A, Hulin C, Manier S, Macro M, Chretien ML, Karlin L, Escoffre M, Jacquet C, Tiab M, Leleu X, Avet-Loiseau H, Jobert A, Planche L, Corre J, Moreau P.
Touzeau C, et al. Among authors: planche l.
Blood. 2024 May 16;143(20):2029-2036. doi: 10.1182/blood.2023023597.
Blood. 2024.
PMID: 38394666
Clinical Trial.